Company/Division name | Vigilent Labs |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Total number of jobs (added or to be added): | 400 |
Year reshoring announced: | 2020 |
Year reshoring implemented or to be implemented: | 2020 |
Domestically, the work will be done: | Both |
Capital investment ($): | 104.6 |
City reshored to: | North Charleston |
State(s) reshored to: | SC |
If relevant, work nearshored to: | - |
Industry(ies): | Medical Equipment & Supplies |
Product(s) reshored | rapid COVID-19 antibody and antigen test kits |
What domestic positive factors made reshoring more attractive? | Skilled workforce availability/training, Other, Covid-19 |